Table 4.
Stage | Derived from SEER | I-ELCAP | NLST |
---|---|---|---|
Status quo scenario, % | Base-case screening scenario, % | Sensitivity analysis screening scenario, % | |
A | 21.7 | 77.9 | 63 |
B | 14.6 | 15.4 | 16.5 |
C | 63.7 | 6.7 | 20.5 |
I-ELCAP indicates for International Early Lung Cancer Action Program; NLST, National Lung Screening Trial; SEER, Surveillance, Epidemiology and End Results.